ITI Pharma And Healthcare Fund - Regular Plan - Growth

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
-7.98 %
Current NAV
15.42
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 200.8 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries15.9 %
Lupin6.3 %
Suven Pharmaceuticals6.1 %
Divi's Laboratories5.7 %
Apollo Hospitals Enterprise5.0 %
Aurobindo Pharma4.7 %

Fund Manager

DS
Dhimant Shah
RK
Rohan Korde
TG
Tanay Gabhawala
RB
Rajesh Bhatia

Fund Information

Launched
10 Nov 2021(3 years ago)
Expense ratio2.35%
Exit LoadExit load of 1% if redeemed within 12 months.
Benchmark index
NIFTY Healthcare TRI.100%

Fund Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Copyright ⓒ 2024 Cherry. All rights reserved.
appstoreplaystore